U.S. Physical Therapy, Inc. (USPH)
After hours:
| Previous Close | 103.39 |
| Open | 102.39 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1000 |
| Day's Range | 102.39 - 104.26 |
| 52 Week Range | 78.08 - 124.11 |
| Volume | |
| Avg. Volume | 71,300 |
| Market Cap | 1.562B |
| Beta (5Y Monthly) | 1.38 |
| PE Ratio (TTM) | 81.61 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.76 (1.70%) |
| Ex-Dividend Date | Mar 11, 2024 |
| 1y Target Est | N/A |
- Business Wire
U.S. Physical Therapy, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call
HOUSTON, April 23, 2024--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2024, on Tuesday, May 7, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, May 8, 2024.
- Business Wire
U.S. Physical Therapy Announces Acquisition of a Nine-Clinic Physical Therapy And Hand Therapy Practice
HOUSTON, April 01, 2024--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with nine clinic locations.
- Business Wire
U.S. Physical Therapy Announces Change in Medicare Rate Reduction for the Remainder of 2024
HOUSTON, March 11, 2024--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE: USPH), reported today that the 3.5% reduction in the Medicare physician fee schedule for therapy services for 2024 (as compared to 2023 rates) has been addressed in the "Consolidated Appropriations Act, 2024" ("Act") signed into law on March 8, 2024. The Act decreased the Medicare reduction for the remainder of 2024; as a result, the Company now estimates that the Medicare rate reduction effective March 9, 2024
